Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Abbv save search
Global Regenerative Medicine Market Size to Grow by USD 28.67 Bn | Increasing prevalence of chronic diseases to boost market growth | Technavio
Published: 2022-05-24 (Crawled : 01:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 0.17%
H: 0.0%
C: 0.0%
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
MDT | $80.38 -1.12% 0.0% 5M
|
Health Technology
|
| O: 0.33%
H: 1.53%
C: 1.39%
BAX | $40.93 -0.22% 0.0% 2.2M
|
Health Technology
|
| O: -1.08%
H: 0.64%
C: 0.56%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -3.09%
H: 0.0%
C: 0.0%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
growth market
AbbVie Presents Positive Data from Phase 3 Study of Cariprazine (VRAYLAR®) for the Adjunctive Treatment of Major Depressive Disorder at 2022 APA Annual Meeting
Published: 2022-05-23 (Crawled : 16:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
vraylar treatment positive phase 3 major depressive disorder
Global $3.12 Billion Head and Neck Cancer Therapeutics Markets, Analysis, Opportunities and Forecasts, 2027
Published: 2022-05-23 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -3.11%
H: 0.0%
C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 5.07%
H: 0.28%
C: -1.81%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: 1.8%
H: 0.26%
C: -0.13%
TEVA | $13.01 -0.68% 7.5M
|
Health Technology
|
| O: 0.94%
H: 0.93%
C: -1.29%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 3.76%
H: 0.0%
C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.61%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 1.61%
H: 1.29%
C: -0.08%
therapeutics cancer
CHMP Recommends European Commission Approval of Upadacitinib (RINVOQ®) for the Treatment of Adults with Moderate to Severe Ulcerative Colitis
Published: 2022-05-23 (Crawled : 07:00) - prnewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
rinvoq treatment chmp approval ulcerative colitis
Intrauterine Devices Market 2022-2026 | Increasing Rate of Unintended Pregnancies and Unwanted Abortions to Boost Growth | Technavio
Published: 2022-05-20 (Crawled : 12:00) - prnewswire.com
VTRS | News A | $11.55 1.67% 1.65% 7.2M
|
Health Technology
|
| O: 5.8%
H: 1.27%
C: 0.25%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.78%
H: 0.0%
C: 0.0%
growth market
Parkinson's Disease (PD) Drugs market - 37% of Growth to Originate from Europe | Evolving Opportunities with AbbVie Inc. & Amneal Pharmaceuticals Inc. | Technavio
Published: 2022-05-18 (Crawled : 07:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.31%
H: 0.53%
C: -0.19%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.43%
H: 0.0%
C: 0.0%
BHC | $8.56 0.35% 0.0% 2M
|
Health Technology
|
| O: -0.72%
H: 1.09%
C: -9.3%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.17%
H: 0.59%
C: -1.52%
ACAD | News | $16.57 -1.02% -1.03% 1.3M
|
Health Technology
|
| O: -3.61%
H: 1.39%
C: -3.14%
europe disease growth market
Monoclonal Antibodies Market to hit USD 425 Billion by 2028, Says Global Market Insights Inc.
Published: 2022-05-17 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 0.55%
H: 0.0%
C: 0.0%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: 0.21%
H: 0.42%
C: 0.14%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 1.63%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 1.08%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 1.71%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 1.74%
H: 1.13%
C: 0.47%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.46%
H: 0.0%
C: 0.0%
market antibody
Vascular Endothelial Growth Factor (VGEF) Inhibitors Market: 36% Market Growth to Originate from North America | Technavio
Published: 2022-05-17 (Crawled : 06:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 4.22%
H: 0.0%
C: -2.05%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 0.55%
H: 0.0%
C: 0.0%
VTRS | News A | $11.55 1.67% 1.65% 7.2M
|
Health Technology
|
| O: 0.54%
H: 3.32%
C: 2.78%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 1.63%
H: 0.0%
C: 0.0%
BHC | $8.56 0.35% 0.0% 2M
|
Health Technology
|
| O: 2.79%
H: 0.0%
C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.46%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.5%
H: 0.64%
C: 0.19%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 3.17%
H: 0.0%
C: 0.0%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
america growth market
Motley Rice, LLC Announces Class Action in the AbbVie Inc. Securities Litigation
Published: 2022-05-16 (Crawled : 14:20) - prnewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
AbbVie to Showcase Depth of Gastroenterology Portfolio and Pipeline at Digestive Disease Week®
Published: 2022-05-16 (Crawled : 13:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
week disease
AbbVie and Cugene Announce Collaboration in Autoimmune Diseases
Published: 2022-05-16 (Crawled : 12:00) - prnewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
collaboration disease
Worldwide Aseptic Pharma Processing Industry to 2027 - Featuring Abbvie, Lonza and Baxter International Among Others
Published: 2022-05-16 (Crawled : 12:00) - prnewswire.com
BAX | $40.93 -0.22% 0.0% 2.2M
|
Health Technology
|
| O: 0.19%
H: 0.99%
C: 0.86%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
pharma international
ABBV DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Investors of AbbVie, Inc. of Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm
Published: 2022-05-14 (Crawled : 20:20) - prnewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
| Email alert
Add to watchlist
deadline
ROSEN, A TOP RANKED LAW FIRM, Encourages Li-Cycle Holdings Corp. f/k/a Peridot Acquisition Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - LICY, PDAC
Published: 2022-05-14 (Crawled : 20:20) - prnewswire.com
LICY | $0.6731 -5.48% 1.9% 2.4M
|
| Email alert
Add to watchlist
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
| Email alert
Add to watchlist
acquisition deadline
AbbVie, Teva May Pay $5 Billion To Settle Opioid Lawsuit
Published: 2022-05-12 (Crawled : 17:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: 0.0%
opioid
AbbVie to Showcase Oncology Portfolio and Pipeline During the 2022 ASCO and EHA Annual Congresses
Published: 2022-05-12 (Crawled : 16:00) - prnewswire.com
FNCTF | News | $11.16 -20.84% 130
|
Communications
|
| O: 0.2%
H: 0.0%
C: -1.1%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: 0.0%
IMAB | $1.805 0.28% 0.28% 110K
|
Health Technology
|
| O: -1.14%
H: 6.45%
C: 4.23%
asco
AbbVie Awards 45 Scholarships to U.S. Students Living with Chronic, Immune-Mediated Diseases in Their Pursuit of Higher Education
Published: 2022-05-12 (Crawled : 13:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: 0.0%
awards education living disease
Genmab Announces Financial Results for the First Quarter of 2022
Published: 2022-05-11 (Crawled : 15:20) - globenewswire.com
GNMSF | News | $290.34 3.83% 340
|
Health Technology
|
| O: -0.51%
H: 2.39%
C: -0.57%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 0.81%
H: 0.0%
C: -0.09%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.27%
H: 1.2%
C: -0.85%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.87%
H: 0.0%
C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
HALO 4 | $39.095 0.32% 0.32% 620K
|
Health Technology
|
| O: 0.94%
H: 2.18%
C: 0.05%
GMAB | News | $28.47 -0.32% -0.32% 460K
|
Health Technology
|
| O: -0.54%
H: 0.96%
C: -4.44%
Upadacitinib (RINVOQ®) Achieved Clinical Remission and Endoscopic Response at One Year in Phase 3 Maintenance Study in Patients with Crohn's Disease
Published: 2022-05-11 (Crawled : 13:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
rinvoq disease response one phase 3
Dementia and Movement Disorder Treatment Market: 45% of Growth to Originate from North America | By Drug Class and Geography - Forecast and Analysis 2022-2026
Published: 2022-05-11 (Crawled : 01:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 0.81%
H: 0.0%
C: -0.09%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.27%
H: 1.2%
C: -0.85%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.65%
H: 1.14%
C: -1.14%
BHC | $8.56 0.35% 0.0% 2M
|
Health Technology
|
| O: 15.69%
H: 13.62%
C: 9.04%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
BIIB | $201.91 4.52% 4.32% 3.3M
|
Health Technology
|
| O: -0.15%
H: 3.04%
C: -0.63%
america treatment dementia drug growth
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.